Role of Activation of Protein Kinase C in the Infarct Size-Limiting Effect of Ischemic Preconditioning Through Activation of Ecto-5′-nucleotidase

Circulation

Volumn 93, Issue 4, 1996, Pages 781-791

  Kitakaze, Masafumi ^a,d   Node, Koichi ^a   Minamino, Tetsuo ^a   Komamura, Kazuo ^a   Funaya, Hiroharu ^a   Shinozaki, Yoshiro ^b   Chujo, Mitsuaki ^b   Mori, Hidezo ^b   Inoue, Michitoshi ^c   Hori, Masatsugu ^a   Kamada, Takenobu ^a  

^a University School of Medicine   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY HOSPITAL   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adenosine; Ecto 5 nucleotidase; Ischemia; Myocardial infarction; Receptors, adrenergic, alpha

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ECTO 5' NUCLEOTIDASE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; NONHUMAN; PRIORITY JOURNAL;

5'-NUCLEOTIDASE; ANIMALS; DOGS; ENZYME ACTIVATION; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; METHOXAMINE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PROTEIN KINASE C; RATS; TIME FACTORS;

EID: 0030033229     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.4.781     Document Type: Article

References (50)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
2. Scott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res. 1990;66: 1133-1142.
3. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation. 1990;82:609-619.
4. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol. 1986;251:H1306-H1315.
5. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 1990;66: 913-931.
6. 2+ exchange during ischemia in preconditioned rat hearts in vitro. Circulation. 1991;84(suppl II): II-210. Abstract.
7. 1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-356.
8. 1-selective adenosine analogue protects the heart against infarction. Circulation. 1992;85:659-665.
9. Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation. 1992;86:979-985.
10. Van Winkle DM, Chien GL, Wolff RA, Soifer BE, Davis RF. Intracoronary infusion of R-phenylisopropyl adenosine prior to ischemia-reperfusion reduces myocardial infarct size in swine. Circulation. 1992;86(suppl I):I-213. Abstract.
11. Thornton JD, Thornton CS, Downey JM. Effect of adenosine receptor blockade: preventing protective preconditioning depends on time of initiation. Am J Physiol. 1993;265:H504-H508.
12. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implication for myocardial salvage. Circulation. 1993;87:208-215.
13. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M, Kamada T. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation. 1994;89:1237-1246.
14. 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest. 1994;93:2197-2205.
15. Imai S, Nakazawa M, Imai H, Jin H. 5′-Nucleotidase inhibitors and the myocardial reactive hyperemia and adenosine content. In: Gerlach E, Becker BF, eds. Topics and Perspectives in Adenosine Research. Berlin, Germany: Springer-Verlag; 1987:416-426.
16. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension. 1991;19:565-574.
17. 1-adrenergic mechanism. Circ Res. 1993;73:656-670.
18. Thornton JD, Daly JF, Cohen MV, Yang XM, Downey JM. Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res. 1993;73:649-655.
19. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res. 1994; 75:576-585.
20. 1-Adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs. Circ Res. 1987;60:631-639.
21. Kitakaze M, Hori M, Kamada T. Role of adenosine and its interaction with alpha adrenoceptor activity in ischemic and reperfusion injury of the myocardium. Cardiovasc Res. 1993;27:18-27.
22. 1-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation. 1995;91:2226-2234.
23. Ytrehus K, Liu Y, Downey J. Preconditioning protects ischemic rabbit heart by protein kinase activation. Am J Physiol. 1994;266: H1145-H1152.
24. Liu Y, Cohen MV, Downey JM. Chelerythrine, a highly selective protein kinase C inhibitor, blocks anti-infarct effect of ischemic preconditioning in rabbit hearts. Circulation. 1994;90(suppl I):I-207. Abstract.
25. Kitakaze M, Minamino T, Shinozaki Y, Sakamoto S, Mori H, Kurihara T, Hori M. Activation of protein kinase C and subsequent activation of ectosolic 5′-nucleotidase as a major cause for the infarct size-limiting effect of ischemic preconditioning. Circulation. 1994;90(suppl I):I-207. Abstract.
26. Speechly-Dick ME, Mocanu MM, Yellon DM. Ischemic preconditioning of the rat myocardium occurs via a protein kinase C-dependent pathway. Circulation. 1994;90(suppl):I-208. Abstract.
27. 2+-dependent protein kinase. Biochem Biophys Res Commun. 1982;109:1129-1133.
28. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771-15781.
29. Mori H, Haruyama S, Shinozaki Y, Okino H, Iida A, Takanashi R, Sakura I, Husseini W, Payne B, Hoffman JIE. New nonradioactive microspheres and more sensitive x-ray fluorescence to measure regional blood flow. Am J Physiol. 1992;263:H1946-H1957.
30. Smith K, Varon HH, Race GJ, Paulson DL, Urshel HC, Mallams JT. Serum 5′-nucleotidase in patients with tumor in the liver. Cancer. 1965;19:1281-1285.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem. 1951;193: 265-275.
32. Snedecor GW, Cochran WG. Statistical Methods. 6th ed. Ames, Iowa: Iowa State University Press; 1972:258-298.
33. Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York, NY: McGraw-Hill Publishing Co; 1982:1-907.
34. 1-Receptor-independent activation of protein kinase C in acute myocardial ischemia: mechanisms for sensitization of the adenylyl cyclase system. Circ Res. 1992;70:1304-1312.
35. Simikhovich BZ, Kloner RA, Przyklenk K. Brief preconditioning ischemia does not trigger translocation of protein kinase C in canine myocardium. Circulation. 1994;90(suppl):I-208. Abstract.
36. Vogt A, Barancik M, Weihrauch D, Arras M, Podzuweit T, Schaper W. Protein kinase C inhibitors reduce infarct size in pig heart in vivo. Circulation. 1994;90(suppl):I-647. Abstract.
37. 1 adenosine receptors prevents sensitization of adenylyl cyclase and activation of protein kinase C in early myocardial ischemia. Drug Develop Res. 1994;31:325. Abstract.
38. Kitakaze M, Node K, Suzuki S, Kamada T. Activation of ectosolic 5′-nucleotidase due to intermittent exposure to adenosine mediates the infarct size-limiting effect: its implication for ischemic preconditioning. Circulation. 1994;90(suppl I):I-647. Abstract.
39. 1 receptor activation in the rat cardiomyocytes. J Clin Invest. 1994;94:2451-2456.
40. Schomig A, Dart AM, Dietz R, Mayer E, Kubler W. Release of endogenous catecholamines in the ischemic myocardium of the rat, part A: locally mediated release. Circ Res. 1984;55:689-701.
41. Goto M, Liu Y, Ardell JL, Cohen MVJ, Downey M. Bradykinin limits myocardial infarction in rabbits by protein kinase C activation and not by nitric oxide synthesis. Circulation. 1994;90(suppl I): I-208. Abstract.
42. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem. 1993;268: 15374-15380.
43. 1-adrenergic receptor subtypes modulate catecholamine-induced increases and decreases in ventricular automaticity. Circ Res. 1990;67:1535-1551.
44. 1-adrenoceptors mediate positive inotropic effect and changes in phosphatidylinositol metabolism: species differences in receptor distribution and the intracellular coupling process in mammalian ventricular myocardium. Circ Res. 1991;68:1179-1190.
45. 1-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation. 1995;91:2226-2234.
46. Jennings RB, Murry CE, Reimer KA. Energy metabolism in preconditioned and control myocardium: effect of total ischemia. J Mol Cell Cardiol. 1991;23:1449-1458.
47. Bunger R, Mallet RT, Kang YH. Guinea-pig cardiac free, bound and interstitial adenylates: energy-linked and energy-independent adenosine release. In: Imai S, Nakazawa M, eds. Role of Adenosine and Adenine Nucleotides in the Biological System. Amsterdam, the Netherlands: Elsevier Science Publishing Co; 1991:337-352.
48. Van Wylen DGL. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation. 1994;89:2283-2289.
49. 1 receptors enhances adhesion of neutrophils in the intact guinea pig coronary system. Cardiovasc Res. 1994;28: 1366-1372.
50. Van Wylen DGL, Willis WJ, Sodhi J, Weiss RJ, Lasley RD, Mentzer RM Jr. Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am J Physiol. 1990;258: H1642-H1649.